In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature

Abstract Background: Recombinant activated factor VII (rFVIIa) is indicated to treat bleeding episodes or prevent bleeding related to surgery in patients with hemophilia A or B who have antibodies to coagulation factors VIII or IX. The first-generation rFVIIa formulation is stable when stored under...

Ausführliche Beschreibung